SAU · 4009.SR · SAR
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 12:13 PM UTC. Cached market data; not a live quote.
One-year closing-price history · SAR. Historical prices are not a forecast.
Middle East Healthcare Company’s quoted price sits in the lower half of its reported 52-week range, 54.08% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Middle East Healthcare Company’s forward annual dividend is SAR 0.50 per share, paid annual. The forward yield is 2.11% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Middle East Healthcare Company’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Middle East Healthcare Company is a prominent medical service provider that manages and operates an extensive network of Saudi German Hospitals throughout the Middle East and North Africa region. These facilities offer comprehensive multi-specialty tertiary care. The company's diverse hospital portfolio includes Saudi German Hospital-Jeddah with 218 beds, Saudi German Hospital-Aseer featuring 400 beds, Saudi German Hospital-Riyadh and Saudi German Hospital-Madinah each equipped with 300 beds, and Saudi German Hospital-Hail providing 150 beds. Expanding its reach further, the network also encompasses Saudi German Hospital-Dammam, offering 150 to 300 beds; Saudi German Hospital-Sanaa and Saudi German Hospital-Dubai, both with 300 beds; Saudi German Hospital-Sharjah, a 50-bed facility; Saudi German Hospital-Ajman, which has between 100 and 200 beds; and Saudi German Hospital-Cairo, accommodating 332 patients. Established in 1988, the company's primary corporate base is situated in Jeddah, Kingdom of Saudi Arabia.
Latest available per-share figures in SAR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 03:12 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| SAR 733.74M+4.45% vs estimate |
| Q4 2024 | Mar 2, 2025 | SAR 0.690.0% vs estimate | SAR 749.00M-4.89% vs estimate |
|---|
| Q3 2024 | Nov 3, 2024 | SAR 0.67+17.72% vs estimate | SAR 732.07M+6.6% vs estimate |
|---|
KEEP COMPARING
SAR 221.50-SAR 1.60 (-0.72%)
Dr. Sulaiman Al Habib Medical Services Group Company’s quoted price sits in the lower half of its reported 52-week range, 18.57% below the high.
SAR 55.20-SAR 0.40 (-0.72%)
Mouwasat Medical Services Company’s quoted price sits in the lower half of its reported 52-week range, 29.23% below the high.
SAR 64.95-SAR 0.65 (-0.99%)
Dallah Healthcare Company’s quoted price sits in the lower half of its reported 52-week range, 49.09% below the high.
SAR 30.32-SAR 0.06 (-0.2%)
Dr. Soliman Abdul Kader Fakeeh Hospital Co.’s quoted price sits in the lower half of its reported 52-week range, 29.23% below the high.
SAR 102.10+SAR 3.50 (+3.55%)
National Medical Care Company’s quoted price sits in the lower half of its reported 52-week range, 42.87% below the high.
SAR 21.43-SAR 0.07 (-0.33%)
Al Hammadi Holding Company’s quoted price sits in the lower half of its reported 52-week range, 38.81% below the high.
SAR 12.97+SAR 0.27 (+2.13%)
Specialized Medical Company’s quoted price sits in the lower half of its reported 52-week range, 39.65% below the high.
SAR 22.00+SAR 0.02 (+0.09%)
Naba Alsaha Medical Services Company’s quoted price sits in the lower half of its reported 52-week range, 28.92% below the high.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
